Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001151 |
Arsenic |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA | affects cotreatment|decreases expression | 19962721
|
D001151 |
Arsenic |
Arsenic results in decreased expression of TNFRSF25 mRNA | decreases expression | 19962721
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TNFRSF25 mRNA | decreases expression | 15761015 17530438
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TNFRSF25 mRNA | decreases expression | 19730151
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of TNFRSF25 mRNA | decreases expression | 19371625
|
D003042 |
Cocaine |
Cocaine affects the expression of TNFRSF25 mRNA | affects expression | 15681117
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of TNFRSF25 mRNA | decreases expression | 19371625
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of TNFRSF25 mRNA | increases expression | 16510352
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of TNFRSF25 mRNA | decreases expression | 16705698
|
D004958 |
Estradiol |
Estradiol results in decreased expression of TNFRSF25 mRNA | decreases expression | 19429434
|
D015025 |
Zearalenone |
Zearalenone results in decreased expression of TNFRSF25 mRNA | decreases expression | 19371625
|
D005459 |
Fluorides |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA | affects cotreatment|decreases expression | 19962721
|
D005459 |
Fluorides |
Fluorides results in decreased expression of TNFRSF25 mRNA | decreases expression | 19962721
|
D005665 |
Furosemide |
Furosemide affects the expression of TNFRSF25 mRNA | affects expression | 17497460
|
D019833 |
Genistein |
Genistein results in decreased expression of TNFRSF25 mRNA | decreases expression | 19371625
|
C071834 |
glycidamide |
glycidamide results in increased expression of TNFRSF25 mRNA | increases expression | 17822822
|
C031927 |
hydroquinone |
hydroquinone results in decreased expression of TNFRSF25 mRNA | decreases expression | 15452088
|
D008345 |
Manganese |
Manganese results in increased expression of TNFRSF25 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of TNFRSF25 mRNA | increases expression | 17175027
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of TNFRSF25 mRNA | increases expression | 12634122
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of TNFRSF25 mRNA | increases expression | 11830524
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of TNFRSF25 mRNA | decreases expression | 19429434
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of TNFRSF25 mRNA | decreases expression | 16705456
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TNFRSF25 mRNA | decreases expression | 18762178
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFRSF25 mRNA | increases expression | 15328365
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased expression of TNFRSF25 mRNA | decreases expression | 19036117
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.74 | 11752688 14514962 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.36 | 19715164 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.37 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.98 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.98 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.98 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.98 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.27 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.11 | 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.10 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.10 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.52 | 15800139 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.37 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
10.69 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
10.69 | 16910769 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.84 | 16835338 12569548 16251483 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.18 | 19371607 12928151 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.62 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.62 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.59 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.85 | 16778634 16121404 17312309 19442620 11697798 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
9.46 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
9.46 | 8053405 15845617 18496637 16769263 11869084 18404659 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.37 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.71 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.65 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
4.65 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
4.65 | 16595493 15692762 18382427 16322301 17983394 16826403 17369602 15993339 18628466 15939500 17426702 15994142 16115903 15136595 19526202 18695136 15567936 16264153 11325840 15634643 16935488 16096432 18234424 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.65 | 16675129 19861407 12948864 17261762 17018787 14630087 17289903 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.65 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.65 | 15758505 16912660 17440819 17242785 17261762 17595753 17049068 15775269 15572757 16837676 17952589 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.65 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
4.65 | 18695136 16096432 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.22 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.53 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
11.17 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
11.17 | 11135700 14691202 16217749 15553829 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
11.17 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
11.17 | 16023760 16234567 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.17 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
11.17 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.88 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.50 | 19233551 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.77 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.81 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
6.81 | 18507039 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.02 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.82 | 15504454 17687452 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.82 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
9.34 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.34 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.46 | 16612575 17924179 16242529 15505089 16455267 16651473 17329180 16952015 15811867 17928571 17007740 16364871 17308081 17351982 17974986 16269455 15476868 17519947 17382496 18627295 17131338 15792986 16109756 16731534 16278810 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.91 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
11.81 | 19152805 17938729 15738583 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
11.81 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
11.81 | 15775269 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.21 | 16973168 18022660 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.86 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
6.86 | 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.64 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 12621046 15340226 15668235 16354765 8697196 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.61 | 19606084 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.51 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.27 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.57 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.57 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.08 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.44 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.44 | 20055451 15322242 10048152 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.45 | 12952375 16002989 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.99 | 15213294 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.07 | 17474826 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.68 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.24 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.24 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.69 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.69 | 15920148 17308373 17451421 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.08 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.08 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.08 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.84 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.84 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.84 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
11.05 | 11834646 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.05 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.05 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.80 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
3.89 | 15845917 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
11.53 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
11.53 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
17.23 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
17.23 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
17.23 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
17.23 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.05 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.28 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.70 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
7.70 | 17473493 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.59 | 15751030 16002989 16513791 16611131 16534752 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.72 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.48 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.84 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.45 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.15 | 16904648 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.84 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.64 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
11.64 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
11.64 | 17043766 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.45 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.73 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.27 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.59 | 16244371 17875725 16144979 18006777 16879835 14766674 17888722 16244372 18674790 16495754 16330681 12587719 16707910 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.59 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.39 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
7.39 | 16011733 16845234 12660669 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.80 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.78 | 12621046 15340226 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.31 | 18501091 15147373 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 16959395 8697196 16354765 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.16 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
10.96 | 17652376 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
10.96 | 18089816 19622757 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.54 | 17652376 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.36 | 17050553 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.77 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.33 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Arsenic |
8.44 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.44 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.44 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.18 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.45 | 16093927 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.09 | 12669777 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.54 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.77 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.47 | 16002989 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.51 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.31 | 15811171 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.25 | 15036965 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.80 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.99 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.99 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
11.99 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.88 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.92 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.92 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
9.92 | 11041285 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.05 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
7.24 | 14681315 16762066 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.24 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.95 | 17184923 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.39 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.25 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.25 | 17468513 18980019 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.05 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
9.63 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
9.63 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.20 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.35 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.66 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.12 | 17050201 16968895 20471514 16467208 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.54 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.54 | 16823087 15748426 11468182 16331271 17649720 17217047 16112521 16330433 19075265 17107899 16966277 15336539 9834237 19642359 15213294 12018890 16891316 17869043 17712046 19035177 12679006 11161223 19225113 12712474 15622746 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.24 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.86 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.86 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
4.86 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.86 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.52 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
10.40 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
10.40 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
10.40 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.40 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
9.46 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.46 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.46 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.26 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.77 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.77 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.77 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.77 | 11884234 19555203 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.04 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
7.48 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.48 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.95 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.70 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.46 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.41 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.76 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.76 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.76 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
13.76 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.65 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
12.65 | 19453300 16568477 16551646 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.27 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.50 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
6.50 | 16675582 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.78 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.40 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.45 | 15863610 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.91 | 16551646 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.68 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.82 | 19549372 19417148 11468182 14977855 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
11.82 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
11.82 | 16996129 18089719 19621390 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.57 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.08 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
9.47 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.47 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.47 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.71 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.71 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.23 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.23 | 17141266 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.45 | 16343187 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.85 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.13 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
6.13 | 15867366 17312309 19139120 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
2.71 | 15313581 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.77 | 15086907 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.66 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.90 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.19 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
29.61 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
29.61 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
29.61 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
29.61 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
29.61 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.21 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.21 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.21 | 15555623 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.27 | 17056641 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.77 | 17945291 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.26 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
11.65 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
11.65 | 17882678 19059307 15775268 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
11.65 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.79 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.79 | 15579764 17893378 15758505 17823083 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.02 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.88 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
11.03 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.03 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.03 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.03 | 19005980 |
MESH:D010146 |
Pain |
|
zoledronic acid |
3.85 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.49 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.06 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.33 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.37 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.07 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.88 | 15371236 16905509 6392382 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.05 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.06 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.56 | 16977796 15687265 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.05 | 17638057 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.54 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
15.65 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
15.65 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.65 | 11118676 11896295 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.21 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
4.22 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.22 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
4.22 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.22 | 17136230 15846301 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.22 | 15749863 15897917 16729912 16868541 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.22 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.22 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
4.22 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
4.22 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
4.22 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
4.22 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.90 | 21343184 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.74 | 16134406 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.68 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.45 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.11 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
3.86 | 16526316 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.51 | 15912074 16096441 12394941 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.89 | 17203757 16767912 18313854 15625365 17710206 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
16.73 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
16.73 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
16.73 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.68 | 17846226 |
MESH:D012640 |
Seizures |
|
Cocaine |
3.97 | 10454489 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.72 | 17453740 16759981 17548696 19834688 17050553 16353154 17938729 18709164 15952646 6392382 16702368 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.22 | 17976673 17029826 15504454 16251483 17050553 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.22 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.22 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.46 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.61 | 16002989 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.82 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.82 | 17052386 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.73 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.88 | 16045194 16684133 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.05 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.05 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.36 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.36 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.85 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
15.38 | 17306315 15987713 19322015 17976673 18640142 19429237 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.38 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
15.38 | 16712894 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.38 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
15.38 | 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
3.94 | 16175088 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
13.46 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
13.46 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.96 | 16690809 15809267 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.33 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.63 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.10 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.11 | 17638931 17334414 17678736 16364871 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.45 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |